ArticleAnnals of surgery2025
Validation of the Back-table Graft Arterial Anastomosis Between the Splenic Artery and Superior Mesenteric Artery: Arterial Complications After a 21-year Single-center Experience of Pancreas Transplantation.
Article in Annals of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- Spontaneous isolated celiac artery dissection mimicking gastrointestinal stromal tumor and causing upper gastrointestinal hemorrhage: a case report.BMC gastroenterology · 2026Article
- Duodenoduodenostomy as an Attractive Option for Exocrine Drainage in Pancreas Transplantation: Insights From a Single-Center Cohort.Transplant international : official journal of the European Society for Organ Transplantation · 2025Article
- Dueling with the dual artery blood supply in pancreas transplantation: why replace the Y?Gland surgery · 2024Article
- Accessibility of Percutaneous Biopsy in Retrocolic-Placed Pancreatic Grafts With a Duodeno-Duodenostomy.Transplant international : official journal of the European Society for Organ Transplantation · 2024Article
Corrections and comments
- Commented on by
Authors and funding
19 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine the role of the arterial splenomesenteric anastomosis (ASMA) vascular reconstruction technique in terms of arterial vascular complications in pancreas transplantation (PT) recipients.
backgroundThe ASMA technique was first described in 1992 by the Hospital Clínic Barcelona group. Regardless that the iliac Y-graft technique is the most frequently used worldwide, evidence of arterial complications and implications of using a different back-table reconstruction is conspicuously absent in the literature.
methodsDescriptive review of 407 PTs performed at a single center (1999-2019) by analyzing the type of arterial reconstruction technique, focusing on ASMA. The end points were the management of arterial complications and long-term patient and graft survival.
resultsASMA was performed in 376 cases (92.4%) and a Y-graft in 31 cases (7.6%). A total of 34 arterial complications (8.3%) were diagnosed. In the ASMA group (n=30, 7.9%), they comprised 15 acute thrombosis, 4 stenosis, 1 pseudoaneurysm, and 10 diverse chronic arterial complications, whereas in the Y-graft group (n=4, 12.9%), 3 acute thrombosis and 1 chronic artery-duodenal fistula occurred. Graft salvage was achieved in 16 patients (53.3%) from the ASMA group and in 2 (50%) from the Y-graft. After a median follow-up of 129.2 (IQR 25-75%, 77.2-182) months, the overall graft and patient survival for the whole cohort at 1, 5, and 10 years were 86.7%, 79.5%, and 70.5%, and 98.5%, 95.3%, and 92.5%, respectively.
conclusionsThe ASMA proves to be a safe and more easily reproducible technique and could therefore be considered a safe alternative vascular reconstruction procedure to the Y-graft in the PT population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.